We are live on
!
Find out more
CCP
Clifford Capital Partners Portfolio holdings
AUM
$600M
1-Year Est. Return
19.57%
This Fund
S&P 500
This Quarter
Est. Return
+0.66%
1 Year Est. Return
+19.57%
3 Year Est. Return
+54.02%
5 Year Est. Return
+53.26%
10 Year Est. Return
–
AUM
$482M
AUM Growth
-$19.8M
(-3.9%)
Cap. Flow
-$21.1M
Cap. Flow
% of AUM
-4.38%
Top 10 Holdings %
Top 10 Hldgs %
36.18%
Holding
59
New
4
Increased
2
Reduced
41
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Keurig Dr Pepper
KDP
|
+$15M |
| 2 |
Henry Schein
HSIC
|
+$13.1M |
| 3 |
Delek US
DK
|
+$7.04M |
| 4 |
Liberty Energy
LBRT
|
+$2.62M |
| 5 |
AMC Global Media
AMCX
|
+$303K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$16.7M |
| 2 |
Pitney Bowes
PBI
|
+$5.87M |
| 3 |
Glacier Bancorp
GBCI
|
+$5.43M |
| 4 |
Warner Bros
WBD
|
+$4.56M |
| 5 |
Perdoceo Education
PRDO
|
+$3.81M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.02% |
| 2 | Technology | 16.55% |
| 3 | Consumer Staples | 14.4% |
| 4 | Industrials | 14.16% |
| 5 | Communication Services | 10.07% |
Similar funds
OCAM
WAM
NPCM
CIG
GP
ERWM
SCM
IECM
Clifford Capital Partners's Q4 2024 Portfolio in Review
As of Q4 2024, Clifford Capital Partners held 59 positions worth $482M, down 3.9% from $502M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Clifford Capital Partners withdrew a net $21.1M in Q4 2024, closing 12 positions and reducing 41 holdings. Its most notable exit was GSK, an estimated $16.7M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Clifford Capital Partners opened a new position in Keurig Dr Pepper worth $14.3M.
- Clifford Capital Partners's largest Q4 2024 buy was Keurig Dr Pepper: 444,470 shares worth $14.3M.
- Clifford Capital Partners added most to Delek US in Q4 2024, an estimated $7.04M increase.
- Clifford Capital Partners's biggest Q4 2024 reduction was Pitney Bowes, cutting an estimated $5.87M.
- Clifford Capital Partners fully exited GSK in Q4 2024, selling an estimated $16.7M.
- Clifford Capital Partners's ten largest holdings make up 36% of its $482M portfolio in Q4 2024.
- Clifford Capital Partners opened 4 new positions and closed 12 in Q4 2024.
- Clifford Capital Partners's portfolio value fell 3.9% quarter-over-quarter to $482M.
Based on Clifford Capital Partners's 13F filing for Q4 2024, filed 14 Feb 2025.